Business
Update on MED2002
Update on MED2002.
About this update from Futura Medical Plc
[{"type":"text","content":"\n Futura Medical PLC\n09 May 2006\n\n\nFor immediate release 9 May 2006\n\n\n Futura Medical plc\n Update on MED2002\n\n\nFutura Medical plc (AIM: FUM), the pharmaceutical drug and medical device group\nthat develops innovative products for sexual health, announces that it has been\nadvised by the major global pharmaceutical group (MGPG) that the formal approval\nprocess is in its final stage.\n\nJames Barder, Futura's Chief Executive, said: 'We are informed by MGPG that\nMED2002 remains a high priority for them.'\n\n\n\nFor further information:\nFutura Medical plc\nJames Barder, Chief Executive Tel: +44 (0) 1483 845 670\nmail to: [email protected] www.futuramedical.co.uk\n\n\nMedia enquiries:\nBuchanan Communications\nMark Court Tel: +44 (0) 20 7466 5000\n\n\nFutura Medical plc\n\nFutura Medical is an AIM-listed pharmaceutical drug and medical device group\ndeveloping innovative products for sexual health. The Company is developing a\nportfolio of products with the intention of licensing their manufacture and\ndistribution to major pharmaceutical and healthcare groups. Exclusive\nworldwide distribution agreements have already been signed in respect of\nFutura's two condom safety products, CSD500 and FLD500, with SSL International\nplc, the makers of DurexTM condoms.\n\nFutura's primary focus is on Over the Counter (OTC) products with particular\nappeal to men and women who are reluctant to discuss potentially embarrassing\nsexual matters with their doctors.\n\n\n\nFor further information please visit: www.futuramedical.co.uk\n\n\n\n\n This information is provided by RNS\n The company news service from the London Stock Exchange \n ","length":2058,"tagName":"div"}]